[PDF] Top 20 Treatment of leukemia relapse after allogeneic hematopoietic stem cell transplantation by donor lymphocyte infusion and STI-571.
Has 10000 "Treatment of leukemia relapse after allogeneic hematopoietic stem cell transplantation by donor lymphocyte infusion and STI-571." found on our website. Below are the top 20 most common "Treatment of leukemia relapse after allogeneic hematopoietic stem cell transplantation by donor lymphocyte infusion and STI-571.".
Treatment of leukemia relapse after allogeneic hematopoietic stem cell transplantation by donor lymphocyte infusion and STI-571.
... Treatment of leukemia relapse after allogeneic hematopoietic stem cell transplantation by donor lymphocyte infusion ... Voir le document complet
2
Preemptive cellular immunotherapy after T-cell-depleted allogeneic hematopoietic stem cell transplantation.
... complication of allogeneic hematopoietic stem cell transplantation ...to donor lymphocytes that are cotransplanted with donor stem ...These donor ... Voir le document complet
9
Post-remission strategies for the prevention of relapse following allogeneic hematopoietic cell transplantation for high-risk acute myeloid leukemia: expert review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
... file and stage and the pre- sence or absence of minimal residual disease (MRD) [ 1 – 3 ...disease relapse accounts for ~ 40% of treatment failures, with a preponderance of ... Voir le document complet
12
Retrospective comparison of CD34-selected allogeneic peripheral blood stem cell transplantation followed by CD8-depleted donor lymphocyte infusions with unmanipulated bone marrow transplantation.
... complication of allogeneic hematopoietic stem cell transplantation (HSCT) 1;2 ...to donor lymphocytes co- transplanted with donor stem cells that are primed ... Voir le document complet
21
Use of Tyrosine Kinase Inhibitors to Prevent Relapse After Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Position Statement of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
... introduction of the BCR-ABL–directed tyrosine kinase inhibitors (TKIs) to the front-line therapy for Ph- positive ALL has improved CR rates, the quality of responses, and the duration of ... Voir le document complet
11
Allogeneic hematopoietic stem cell transplantation in solid organ transplant recipients: a retrospective, multicenter study of the EBMT
... of children in this situation ...occurs after 1–3% of liver and kidney, 3–9% of heart and lung and up to 10% of intestinal or multiorgan transplants ...risk ... Voir le document complet
10
Prediction of Allogeneic Hematopoietic Stem-Cell Transplantation Mortality 100 Days After Transplantation Using a Machine Learning Algorithm: A European Group for Blood and Marrow Transplantation Acute Leukemia Working Party Retrospective Data Mining Study
... mortality after allo-HSCT. The model was devel- oped using a DM approach and internally validated on a large data set with excellent ...online and provides a personalized estimation of day 100 ... Voir le document complet
10
Recombinant human erythropoietin therapy after allogeneic hematopoietic cell transplantation with a nonmyeloablative conditioning regimen: low donor chimerism predicts for poor response.
... observed after NMSCT was sig- nificantly lower than the one obtained after HCT with a myeloablative conditioning regimen, we attempted at identifying factors that could be associated with response to rHuEPO ... Voir le document complet
10
A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia
... improve stem cell transplantation or cellular therapy, which includes regis- tering all the activity relating to stem cell ...managed, and maintained in a central database with ... Voir le document complet
9
ABO incompatibility in mismatched unrelated donor allogeneic hematopoietic cell transplantation for acute myeloid leukemia: A report from the acute leukemia working party of the EBMT.
... design and data collection This multicenter retrospective analysis was approved by the ALWP, in accordance with the EBMT guidelines for retrospective ...group of more than 500 transplant depart- ... Voir le document complet
8
Alternative donor hematopoietic stem cell transplantation for mature lymphoid malignancies after reduced-intensity conditioning regimen: similar outcomes with umbilical cord blood and unrelated donor peripheral blood
... collaboration of the fol- lowing transplant centers (in alphabetical order) that submitted data for this study: Addenbrookes Hospital, Cambridge University Hospital, Cambridge, UK; Asklepios Klinik ...Hospital ... Voir le document complet
9
Impact of HLA-G polymorphism on the outcome of allogeneic hematopoietic stem cell transplantation for metastatic renal cell carcinoma
... peri- and post-transplant variables were collected from the participating centers and information were updated as of September ...patient and donor age, gender and CMV ... Voir le document complet
6
Pegfilgrastim compared with Filgrastim after autologous hematopoietic peripheral blood stem cell transplantation.
... doses of Filgrastim were given when the ANC fell below 1 3 10 9 /L at any time before day 100 ...rooms and received chlorhexidine ...intravenously and then orally as soon as feasible until day 40), ... Voir le document complet
7
Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioning
... incidence of TMA in all patients as well as in patients given high-dose or nonmyeloablative condition- ing was calculated as described ...variables and TMA were assessed using the w 2 tests or the Fisher’s ... Voir le document complet
5
Use of chimerism analysis after allogeneic stem cell transplantation: Belgian guidelines and review of the current literature
... disease relapse or graft rejection has been described in a considerable number of patients after HSCT for nonmalignant dis- ease and has been described as late as 13 years post- HSCT in ... Voir le document complet
10
Comparison of Immune Reconstitution after Hematopoietic Stem Cell Transplantation with Flu-TBI versus TLI-ATG Conditioning
... consisted of either 2 Gy TBI with 90 mg/m fludarabine (=TBI arm, n=21), or 8 Gy TLI plus thymoglobulin (ATG) ...yrs and 61 yrs in the TBI and TLI arms, ... Voir le document complet
1
Low non-relapse mortality and long-term preserved quality of life in older patients undergoing matched related donor allogeneic stem cell transplantation: a prospective multicenter phase II trial
... role of in vivo T-cell depletion even in the setting of MRD, which was recently confirmed in the large European Group for Blood and Marrow Transplantation ...safety and efficacy ... Voir le document complet
7
Unrelated donor haemopoietic stem-cell transplantation: ATG or not?
... reported by Finke and colleagues suggest that ATLG could be the standard of care for patients receiving peripheral blood stem- cells from unrelated donors after myeloablative ... Voir le document complet
2
Yellow nail syndrome after allogeneic haematopoietic stem cell transplantation in two patients with multiple myeloma
... characterized by the triad of yellow nails, lym- phoedema and respiratory ...two of the three features are required. A lot of patients probably elude proper diagnosis because of ... Voir le document complet
4
Late effects after hematopoietic stem cell transplantation for β-thalassemia major: the French national experience
... geneic hematopoietic stem cell transplantation in ...age of 5.9 years at transplantation. The median duration of clinical follow up was 12 ...cyclophosphamide, and ... Voir le document complet
8
Sujets connexes